Fisher And Paykel Healthcare Corpo revenue and financials
$37.69Change from previous close: +0.96%Absolute change: +$0.36
In the fiscal year ended March 2026, Fisher And Paykel Healthcare Corpo reported revenue of $2.31B (+80.30% year over year). Net income was $468.5M, a net margin of 20.3%.
Fiscal year ending in March. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +80.30%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +24.20%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 20.3%
- FY to Mar 2025: 29.5%
Financial data
Amounts in millions of NZD; per-share values in NZD; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 |
|---|---|---|---|---|---|
| Capital expenditure | -195 | -103 | -339 | -211 | — |
| Investing cash flow | -195 | -103 | -339 | -11.3 | — |
| Financing cash flow | -277 | -268 | -129 | -197 | — |
| Dividends paid | -252 | -196 | -146 | -196 | — |
| Debt issued | 52.5 | 107 | 301 | 138 | — |
| Debt repaid | -59.7 | -164 | -270 | -128 | — |
| Effect of exchange rates | 2.3 | 1.9 | 2.2 | 2.4 | — |
| Net change in cash | 191 | 177 | -38.1 | 29.8 | — |
| Free cash flow | 468 | 446 | 90.6 | 26.9 | — |